State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.97B |
| 2 |
Apple
AAPL
|
+$2.88B |
| 3 |
Microsoft
MSFT
|
+$2.36B |
| 4 |
Parker-Hannifin
PH
|
+$2.29B |
| 5 |
Sherwin-Williams
SHW
|
+$2.05B |
Top Sells
| 1 |
Chevron
CVX
|
+$1.37B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$967M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$451M |
| 4 |
Marathon Petroleum
MPC
|
+$244M |
| 5 |
Dow Inc
DOW
|
+$217M |
Sector Composition
| 1 | Technology | 29.35% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 10.66% |
| 4 | Healthcare | 10.51% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Eletrobras Preferred Shares
EBR.B
$20.1B
| $1.01M | ﹤0.01% |
151,104
-27
| -0% | -$180 |
|
3302
908 Devices
MASS
$206M
| $1.01M | ﹤0.01% |
457,347
-21,697
| -5% | -$47.7K |
|
3303
NL Industries
NL
$298M
| $1M | ﹤0.01% |
128,800
-500
| -0.4% | -$3.89K |
|
|
AKYA
3304
DELISTED
Akoya BioSciences
AKYA
| $998K | ﹤0.01% |
435,830
-17,466
| -4% | -$40K |
|
|
JBIO
3305
Jade Biosciences, Inc. Common Stock
JBIO
$247M
| $995K | ﹤0.01% |
10,725
+226
| +2% | +$21K |
|
3306
GoHealth
GOCO
$75.9M
| $986K | ﹤0.01% |
73,671
+1,800
| +3% | +$24.1K |
|
|
PAMT
3307
PAMT CORP Common Stock
PAMT
$253M
| $975K | ﹤0.01% |
59,552
+2,220
| +4% | +$36.4K |
|
3308
Innoviz Technologies
INVZ
$347M
| $973K | ﹤0.01% |
579,272
-242,922
| -30% | -$408K |
|
3309
Shattuck Labs
STTK
$83.8M
| $967K | ﹤0.01% |
799,460
+33,050
| +4% | +$40K |
|
3310
Purple Innovation
PRPL
$116M
| $965K | ﹤0.01% |
1,237,056
+39,848
| +3% | +$31.1K |
|
3311
AbCellera Biologics
ABCL
$1.28B
| $952K | ﹤0.01% |
324,802
+1,573
| +0.5% | +$4.61K |
|
3312
Stratasys
SSYS
$834M
| $949K | ﹤0.01% |
106,713
+1,135
| +1% | +$10.1K |
|
3313
Ultralife
ULBI
$112M
| $943K | ﹤0.01% |
126,591
+9,004
| +8% | +$67.1K |
|
3314
Trinity Capital
TRIN
$1.13B
| $940K | ﹤0.01% |
62,778
+1,608
| +3% | +$24.1K |
|
3315
C&F Financial
CFFI
$228M
| $938K | ﹤0.01% |
13,086
+766
| +6% | +$54.9K |
|
|
RERE
3316
ATRenew
RERE
$928M
| $936K | ﹤0.01% |
324,872
+19,553
| +6% | +$56.3K |
|
3317
Inovio Pharmaceuticals
INO
$140M
| $923K | ﹤0.01% |
504,308
+13,646
| +3% | +$25K |
|
3318
Braskem
BAK
$1.31B
| $923K | ﹤0.01% |
239,027
+10,917
| +5% | +$42.1K |
|
3319
Valhi
VHI
$453M
| $921K | ﹤0.01% |
39,389
+1,803
| +5% | +$42.2K |
|
|
EVBN
3320
DELISTED
Evans Bancorp Inc
EVBN
| $910K | ﹤0.01% |
21,011
+4,191
| +25% | +$181K |
|
|
PWOD
3321
DELISTED
Penns Woods Bancorp
PWOD
| $910K | ﹤0.01% |
29,928
+2,121
| +8% | +$64.5K |
|
3322
XBiotech
XBIT
$85.4M
| $907K | ﹤0.01% |
229,695
+5,100
| +2% | +$20.1K |
|
3323
Cibus
CBUS
$73M
| $905K | ﹤0.01% |
325,538
+18,276
| +6% | +$50.8K |
|
3324
Acumen Pharmaceuticals
ABOS
$81.8M
| $904K | ﹤0.01% |
525,806
+9,400
| +2% | +$16.2K |
|
3325
DLH Holdings
DLHC
$79.4M
| $902K | ﹤0.01% |
112,387
+940
| +0.8% | +$7.55K |
|